MOGAMULIZUMAB-KPKC

1361 reported adverse events

Drug classes: Chemokine Receptor Type 4 Interaction [EPC] Monoclonal Antibody [EPC]

These side effects are most commonly reported by patients taking MOGAMULIZUMAB-KPKC:

# Side effect Count
0 RASH 193
1 DISEASE PROGRESSION 123
2 DRUG ERUPTION 81
3 PRURITUS 68
4 INFUSION RELATED REACTION 59
5 DEATH 55
6 PYREXIA 52
7 FATIGUE 49
8 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 42
9 CHILLS 41
See all common reactions for MOGAMULIZUMAB-KPKC

MOGAMULIZUMAB-KPKC is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 RADIOTHERAPY TO TONGUE 1 1.0000
1 SEZARY CELLS INCREASED 2 0.2500
2 CUTANEOUS T-CELL LYMPHOMA RECURRENT 5 0.0794
3 AUTOIMMUNE VASCULITIS 1 0.0588
4 LYMPHODEPLETION 2 0.0588
5 PHOTOPHERESIS 1 0.0556
6 PSEUDOMONAL SKIN INFECTION 1 0.0417
7 LISTERAEMIA 1 0.0400
8 IMMUNOLOGY TEST 1 0.0370
9 THERAPY NAIVE 4 0.0323
See all enriched reactions for MOGAMULIZUMAB-KPKC